Hiroto Inaba1,2, Olga Varechtchouk1, Michael D Neel3, Matthew J Ehrhardt1,2,4, Monika L Metzger1,2,5, Seth E Karol1,2, Kirsten K Ness4, Raul C Ribeiro1,2, Ching-Hon Pui1,2, Mary V Relling6,7, John T Sandlund1,2, Sue C Kaste1,8,9. 1. Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee. 3. Department of Surgery, St Jude Children's Research Hospital, Memphis, Tennessee. 4. Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee. 5. Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee. 6. Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee. 7. Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee. 8. Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee. 9. Department of Radiology, University of Tennessee Health Science Center, Memphis, Tennessee.
Abstract
BACKGROUND: Osteonecrosis is a debilitating complication in children and adolescents with acute lymphoblastic leukemia or acute lymphoblastic lymphoma (LLy). An objective screening test to identify patients at risk for symptomatic, extensive joint involvement will help manage osteonecrosis. METHODS: We performed a prospective, longitudinal pilot study with whole-joint magnetic resonance imaging (MRI) of shoulders, elbows, hips, knees, ankles, and hindfeet to evaluate the incidence and timing of osteonecrosis involving multiple joints in 15 patients with LLy aged 9-21 years at diagnosis. RESULTS: Osteonecrosis affecting ≥30% of the epiphysis occurred in eight of 15 patients, with a high prevalence in hips (12 of 26 examined [46%]) and knees (10 of 26 [38%]) post reinduction I and in shoulders (seven of 20 [35%]) post reinduction II. Most osteonecrotic hips and knees with ≥30% epiphyseal involvement became symptomatic and/or underwent surgery (100% and 82%, respectively). All eight patients with ≥30% epiphyseal involvement had multijoint involvement. Seven of these patients had hip or knee osteonecrosis by the end of remission induction, and only these patients developed osteonecrosis that became symptomatic and/or underwent surgery in their hips, knees, shoulders, ankles, and/or feet; all of these joints were associated with epiphyseal abnormalities on post reinduction I imaging. CONCLUSIONS: MRI screening in adolescent patients with LLy revealed osteonecrosis in multiple joints. Initial screening with hip and knee MRI at the end of induction may identify susceptible patients who could benefit from referrals to subspecialties, more extensive follow-up imaging of other joints, and early medical and surgical interventions.
BACKGROUND:Osteonecrosis is a debilitating complication in children and adolescents with acute lymphoblastic leukemia or acute lymphoblastic lymphoma (LLy). An objective screening test to identify patients at risk for symptomatic, extensive joint involvement will help manage osteonecrosis. METHODS: We performed a prospective, longitudinal pilot study with whole-joint magnetic resonance imaging (MRI) of shoulders, elbows, hips, knees, ankles, and hindfeet to evaluate the incidence and timing of osteonecrosis involving multiple joints in 15 patients with LLy aged 9-21 years at diagnosis. RESULTS:Osteonecrosis affecting ≥30% of the epiphysis occurred in eight of 15 patients, with a high prevalence in hips (12 of 26 examined [46%]) and knees (10 of 26 [38%]) post reinduction I and in shoulders (seven of 20 [35%]) post reinduction II. Most osteonecrotic hips and knees with ≥30% epiphyseal involvement became symptomatic and/or underwent surgery (100% and 82%, respectively). All eight patients with ≥30% epiphyseal involvement had multijoint involvement. Seven of these patients had hip or knee osteonecrosis by the end of remission induction, and only these patients developed osteonecrosis that became symptomatic and/or underwent surgery in their hips, knees, shoulders, ankles, and/or feet; all of these joints were associated with epiphyseal abnormalities on post reinduction I imaging. CONCLUSIONS: MRI screening in adolescent patients with LLy revealed osteonecrosis in multiple joints. Initial screening with hip and knee MRI at the end of induction may identify susceptible patients who could benefit from referrals to subspecialties, more extensive follow-up imaging of other joints, and early medical and surgical interventions.
Authors: Leonard A Mattano; Meenakshi Devidas; James B Nachman; Harland N Sather; Stephen P Hunger; Peter G Steinherz; Paul S Gaynon; Nita L Seibel Journal: Lancet Oncol Date: 2012-08-15 Impact factor: 41.316
Authors: Sue C Kaste; Brian M DeFeo; Michael D Neel; Kenneth S Weiss; Israel Fernandez-Pineda; Kiri K Ness Journal: J Pediatr Orthop Date: 2019-02 Impact factor: 2.324
Authors: Sue C Kaste; Deqing Pei; Cheng Cheng; Michael D Neel; W Paul Bowman; Raul C Ribeiro; Monika L Metzger; Deepa Bhojwani; Hiroto Inaba; Patrick Campbell; Jeffrey E Rubnitz; Sima Jeha; John T Sandlund; James R Downing; Mary V Relling; Ching-Hon Pui; Scott C Howard Journal: J Clin Oncol Date: 2015-01-20 Impact factor: 44.544
Authors: Laura J Janke; Chengcheng Liu; Peter Vogel; Jitesh Kawedia; Kelli L Boyd; Amy J Funk; Mary V Relling Journal: Am J Pathol Date: 2013-05-11 Impact factor: 4.307
Authors: Seth E Karol; Leonard A Mattano; Wenjian Yang; Kelly W Maloney; Colton Smith; ChengCheng Liu; Laura B Ramsey; Christian A Fernandez; Tamara Y Chang; Geoffrey Neale; Cheng Cheng; Elaine Mardis; Robert Fulton; Paul Scheet; F Anthony San Lucas; Eric C Larsen; Mignon L Loh; Elizabeth A Raetz; Stephen P Hunger; Meenakshi Devidas; Mary V Relling Journal: Blood Date: 2015-11-20 Impact factor: 22.113
Authors: Evguenia J Karimova; Shesh N Rai; Scott C Howard; Michael Neel; Lunetha Britton; Ching-Hon Pui; Sue C Kaste Journal: J Clin Oncol Date: 2007-04-20 Impact factor: 44.544
Authors: Alexandra Podpeskar; Roman Crazzolara; Gabriele Kropshofer; Petra Obexer; Evelyn Rabensteiner; Miriam Michel; Christina Salvador Journal: Front Pediatr Date: 2022-09-12 Impact factor: 3.569